---
title: "The Shanghai Stock Exchange issued regulatory warnings to EAST-ASIA PHARMACEUTICAL and relevant responsible persons"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262217527.md"
description: "The Shanghai Stock Exchange issued a regulatory warning to Zhejiang East-Asia Pharmaceutical and related responsible persons due to discrepancies between the use of some raised funds and the initial public offering prospectus, failure to timely fulfill review procedures, and inaccurate information disclosure regarding the storage and actual use of raised funds. These actions violate relevant regulations"
datetime: "2025-10-22T10:56:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262217527.md)
  - [en](https://longbridge.com/en/news/262217527.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262217527.md)
---

# The Shanghai Stock Exchange issued regulatory warnings to EAST-ASIA PHARMACEUTICAL and relevant responsible persons

The Shanghai Stock Exchange issued a decision to impose regulatory warnings on Zhejiang East Asia Pharmaceutical Co., Ltd. and relevant responsible persons. According to the facts established in the "Decision on Ordering Zhejiang East Asia Pharmaceutical Co., Ltd. to Rectify" (〔2025〕 No. 224) issued by the Zhejiang Securities Regulatory Bureau, the company’s use of part of the raised funds is inconsistent with the purposes disclosed in the prospectus for its initial public offering. The company failed to timely fulfill the review procedures, and the relevant information disclosure regarding the storage and actual use of the raised funds was inaccurate. The above actions violated relevant regulations

### Related Stocks

- [605177.CN](https://longbridge.com/en/quote/605177.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [Rare nickels that could fund your dreams](https://longbridge.com/en/news/286856785.md)
- [Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions](https://longbridge.com/en/news/286794376.md)